Medexus Pharmaceuticals Inc's total assets for Q4 2024 were $171.84M, an increase of 17.71% from the previous quarter. TSE:MDP total liabilities were $119.69M for the fiscal quarter, a 6.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.